Published in Atherosclerosis on April 01, 2000
Glycoxidative stress and cardiovascular complications in experimentally-induced diabetes: effects of antioxidant treatment. Open Cardiovasc Med J (2010) 0.92
Use of hamster as a model to study diet-induced atherosclerosis. Nutr Metab (Lond) (2010) 0.85
Site-specific antioxidative therapy for prevention of atherosclerosis and cardiovascular disease. Oxid Med Cell Longev (2013) 0.79
In vitro study of lovastatin interactions with amiodarone and with carbon tetrachloride in isolated rat hepatocytes. World J Gastroenterol (2007) 0.75
Effect of Lovastatin on lipid peroxidation and total antioxidant concentrations in hemodialysis patients. Lipids Health Dis (2004) 0.75
Antioxidative and antiatherogenic effects of flaxseed, α-tocopherol and their combination in diabetic hamsters fed with a high-fat diet. Exp Ther Med (2014) 0.75
Gemfibrozil for the secondary prevention of coronary heart disease in men with low levels of high-density lipoprotein cholesterol. Veterans Affairs High-Density Lipoprotein Cholesterol Intervention Trial Study Group. N Engl J Med (1999) 9.83
THE EFFECT OF COMBINATION WITH DIAZO COMPOUNDS ON THE IMMUNOLOGICAL REACTIVITY OF ANTIBODIES. J Exp Med (1936) 7.43
Mal (MyD88-adapter-like) is required for Toll-like receptor-4 signal transduction. Nature (2001) 5.95
Effect of Gibberellin on Germination of Lettuce Seed. Science (1957) 5.27
Weight gain continues in the 1990s: 10-year trends in weight and overweight from the CARDIA study. Coronary Artery Risk Development in Young Adults. Am J Epidemiol (2000) 4.49
Association between plasma homocysteine concentrations and extracranial carotid-artery stenosis. N Engl J Med (1995) 4.36
Evidence for association and genetic linkage of the angiotensin-converting enzyme locus with hypertension and blood pressure in men but not women in the Framingham Heart Study. Circulation (1998) 3.89
Vitamin E supplementation and in vivo immune response in healthy elderly subjects. A randomized controlled trial. JAMA (1997) 3.68
Elevated plasma lipoprotein(a) and coronary heart disease in men aged 55 years and younger. A prospective study. JAMA (1996) 3.68
Relaxation of a single DNA molecule observed by optical microscopy. Science (1994) 3.58
Stretching of a single tethered polymer in a uniform flow. Science (1995) 3.48
Oxidants as stimulators of signal transduction. Free Radic Biol Med (1997) 3.43
Minimally modified low density lipoprotein stimulates monocyte endothelial interactions. J Clin Invest (1990) 3.40
Endotoxin and tumor necrosis factor induce interleukin-1 gene expression in adult human vascular endothelial cells. Am J Pathol (1986) 3.35
Relation of gemfibrozil treatment and lipid levels with major coronary events: VA-HIT: a randomized controlled trial. JAMA (2001) 3.12
Lipoprotein(a) levels and risk of coronary heart disease in men. The lipid Research Clinics Coronary Primary Prevention Trial. JAMA (1994) 3.11
Estrogen in the prevention of atherosclerosis. A randomized, double-blind, placebo-controlled trial. Ann Intern Med (2001) 3.03
Single polymer dynamics in an elongational flow. Science (1997) 2.92
Automated enzymatic standardized lipid analyses for plasma and lipoprotein fractions. Clin Chim Acta (1987) 2.70
Direct observation of tube-like motion of a single polymer chain. Science (1994) 2.60
A new nomenclature for IL-1-family genes. Trends Immunol (2001) 2.57
Cysteine Protection against X Irradiation. Science (1949) 2.52
Absence of association or genetic linkage between the angiotensin-converting-enzyme gene and left ventricular mass. N Engl J Med (1996) 2.49
Quantification of mRNA by polymerase chain reaction (PCR) using an internal standard and a nonradioactive detection method. Methods Mol Biol (1998) 2.39
Hydrogen mapping of the lunar south pole using the LRO neutron detector experiment LEND. Science (2010) 2.38
Effects of different forms of dietary hydrogenated fats on serum lipoprotein cholesterol levels. N Engl J Med (1999) 2.33
Portacaval shunt in patients with familial hypercholesterolemia. Ann Surg (1983) 2.33
Characterization of monoclonal antibody to DNA.RNA and its application to immunodetection of hybrids. J Immunol Methods (1986) 2.31
Pathogenesis and management of lipoprotein disorders. N Engl J Med (1985) 2.31
Normal high density lipoprotein inhibits three steps in the formation of mildly oxidized low density lipoprotein: steps 2 and 3. J Lipid Res (2000) 2.22
Inducible interleukin-1 gene expression in human vascular smooth muscle cells. J Clin Invest (1986) 2.21
Gamma-hydroxybutyrate: an emerging drug of abuse that causes physical dependence. Addiction (1997) 2.12
Retinoid signaling and activator protein-1 expression in ferrets given beta-carotene supplements and exposed to tobacco smoke. J Natl Cancer Inst (1999) 2.11
Genetic and non-genetic correlates of vitamins K and D. Eur J Clin Nutr (2007) 2.10
Association of cholesteryl ester transfer protein-TaqIB polymorphism with variations in lipoprotein subclasses and coronary heart disease risk: the Framingham study. Arterioscler Thromb Vasc Biol (2000) 2.10
Crystalloid vs. colloid resuscitation: is one better? A randomized clinical study. Surgery (1979) 2.06
Seven-year trends in body weight and associations with lifestyle and behavioral characteristics in black and white young adults: the CARDIA study. Am J Public Health (1997) 2.01
Apolipoprotein E epsilon4 association with dementia in a population-based study: The Framingham study. Neurology (1996) 2.00
Cardiovascular features of homozygous familial hypercholesterolemia: analysis of 16 patients. Am J Cardiol (1984) 1.99
Expression pattern of Motch, a mouse homolog of Drosophila Notch, suggests an important role in early postimplantation mouse development. Development (1992) 1.99
Abnormal in vivo metabolism of apolipoprotein E4 in humans. J Clin Invest (1986) 1.98
Human fibronectin binding to staphylococcal surface protein and its relative inefficiency in promoting phagocytosis by human polymorphonuclear leukocytes, monocytes, and alveolar macrophages. Infect Immun (1981) 1.97
An ethics core curriculum for Australasian medical Schools. Med J Aust (2001) 1.95
Uric acid-iron ion complexes. A new aspect of the antioxidant functions of uric acid. Biochem J (1986) 1.94
Evidence for a gene influencing the TG/HDL-C ratio on chromosome 7q32.3-qter: a genome-wide scan in the Framingham study. Hum Mol Genet (2000) 1.94
Dietary vitamin K intakes are associated with hip fracture but not with bone mineral density in elderly men and women. Am J Clin Nutr (2000) 1.87
Familial apolipoprotein E deficiency. J Clin Invest (1986) 1.87
Familial lipoprotein disorders in patients with premature coronary artery disease. Circulation (1992) 1.84
Type III hyperlipoproteinemia associated with apolipoprotein E deficiency. Science (1981) 1.84
Apolipoprotein E genotype and cardiovascular disease in the Framingham Heart Study. Atherosclerosis (2001) 1.84
Vitamin E supplementation enhances cell-mediated immunity in healthy elderly subjects. Am J Clin Nutr (1990) 1.80
Dawn at Vesta: testing the protoplanetary paradigm. Science (2012) 1.76
Lack of efficacy of a food-frequency questionnaire in assessing dietary macronutrient intakes in subjects consuming diets of known composition. Am J Clin Nutr (2000) 1.76
Tick anticoagulant peptide (TAP) is a novel inhibitor of blood coagulation factor Xa. Science (1990) 1.75
How reliably can compact chemistry analyzers measure lipids? JAMA (1990) 1.73
Dietary saturated fatty acids: a novel treatment for alcoholic liver disease. Gastroenterology (1995) 1.72
Internal structure and early thermal evolution of Mars from Mars Global Surveyor topography and gravity. Science (2000) 1.71
Mechanisms and consequences of lipid peroxidation in biological systems. Annu Rev Nutr (1985) 1.71
Apolipoprotein E alleles, dyslipidemia, and coronary heart disease. The Framingham Offspring Study. JAMA (1994) 1.71
Apolipoprotein A-I gene polymorphism associated with premature coronary artery disease and familial hypoalphalipoproteinemia. N Engl J Med (1986) 1.70
Postprandial plasma lipoprotein changes in human subjects of different ages. J Lipid Res (1988) 1.67
Effect of platelet activating factor-acetylhydrolase on the formation and action of minimally oxidized low density lipoprotein. J Clin Invest (1995) 1.66
Impact of body mass index on coronary heart disease risk factors in men and women. The Framingham Offspring Study. Arterioscler Thromb Vasc Biol (1996) 1.65
Steady-state pharmacokinetics of delavirdine in HIV-positive patients: effect on erythromycin breath test. Clin Pharmacol Ther (1997) 1.64
Lipoprotein(a)-cholesterol and coronary heart disease in the Framingham Heart Study. Clin Chem (1999) 1.64
Absence of P-selectin delays fatty streak formation in mice. J Clin Invest (1997) 1.63
Effects of age, gender, and menopausal status on plasma low density lipoprotein cholesterol and apolipoprotein B levels in the Framingham Offspring Study. J Lipid Res (1994) 1.62
Ancient geodynamics and global-scale hydrology on Mars. Science (2001) 1.61
Interleukin-1-induced anorexia in the rat. Influence of prostaglandins. J Clin Invest (1989) 1.61
Apolipoprotein E alleles and risk of coronary disease. A meta-analysis. Arterioscler Thromb Vasc Biol (1996) 1.60
Localization of PEPT1 and PEPT2 proton-coupled oligopeptide transporter mRNA and protein in rat kidney. Am J Physiol (1999) 1.59
Drosophila nuclear lamin precursor Dm0 is translated from either of two developmentally regulated mRNA species apparently encoded by a single gene. J Cell Biol (1988) 1.59
Plasma apolipoprotein A-1 absence associated with a marked reduction of high density lipoproteins and premature coronary artery disease. Arteriosclerosis (1982) 1.57
The influence of phospholipase A2 and glutathione peroxidase on the elimination of membrane lipid peroxides. Arch Biochem Biophys (1983) 1.55
Individual variability in lipoprotein cholesterol response to National Cholesterol Education Program Step 2 diets. Am J Clin Nutr (1997) 1.54
Immunological identification of two sulfhydryl-containing fragments of human plasma fibronectin. J Biol Chem (1982) 1.52
Low density lipoprotein particle size and coronary artery disease. Arterioscler Thromb (1992) 1.52
Lymphogranuloma venereum. I. Comparison of the Frei test, complement fixation test, and isolation of the agent. J Infect Dis (1969) 1.52
Adjuvant arthritis as a model of inflammatory cachexia. Arthritis Rheum (1997) 1.51
Distribution of ApoA-I-containing HDL subpopulations in patients with coronary heart disease. Arterioscler Thromb Vasc Biol (2000) 1.49
Apolipoprotein E isoform phenotyping methodology and population frequency with identification of apoE1 and apoE5 isoforms. J Lipid Res (1987) 1.49